SOLVING SCALE-UP CHALLENGES IN DRUG SUBSTANCE MANUFACTURING
In the pharmaceutical world, scaling up drug substance (API) manufacturing is a critical bridge between scientific innovation and patient access.
19 December 2025
Read More
BLOGS
Blogs
FROM SUPPLY CHAIN RISK TO SUPPLY CHAIN ADVANTAGE: HOW INDIAN CDMOs ARE MOVING UP THE VALUE CHAIN
For more than a decade, pharma and biotech companies have lived with an uncomfortable truth: their supply chains are efficient, but fragile. COVID-19, geopolitical tensions, export controls, and logistics disruptions exposed a harsh reality that overdependence on a limited set...
22 December 2025
Read MoreFROM MOLECULE TO MARKET: ROLE OF INTEGRATED CDMOs IN SPEEDING UP THE TIMELINES
The journey from discovering a promising molecule to making it available in the market as a life-saving therapy is long, complex, and expensive.
23 December 2025
Read MoreTHE EVOLUTION OF THE CDMO MODEL: FROM MANUFACTURING CONTRACTOR TO INNOVATION PARTNER
Not too long ago, Contract Development and Manufacturing Organizations (CDMOs) were viewed simply as “the builders”, facilities where pharmaceutical companies outsourced production to save time or reduce costs. Their value was measured in efficiency, compliance, and scale.
24 December 2025
Read MoreWHAT IS A CDMO? A COMPLETE GUIDE FOR PHARMA INNOVATORS
In today’s fast-evolving pharmaceutical landscape, speed, scalability, and specialization are critical to success. That’s where Contract Development and Manufacturing Organizations (CDMOs) come in. For pharma innovators, from startups to global giants, CDMOs offer a strategic pathway to bring therapies from lab to...
25 December 2025
Read MoreHIGH POTENCY APIs (HPAPIs): WHAT MAKES MANUFACTURING THEM SO COMPLEX?
Over the last decade, the global pharmaceutical industry has witnessed a surge in the development of high potency active pharmaceutical ingredients (HPAPIs). These highly targeted molecules often used in oncology, autoimmune diseases, and hormonal therapies offer extraordinary therapeutic power in microgram-level...
26 December 2025
Read MoreDEMYSTIFYING cGMP COMPLIANCE IN API MANUFACTURING: WHAT SPONSORS MUST KNOW
In the pharmaceutical world, three little letters carry enormous weight: cGMP that stands for current Good Manufacturing Practices.
13 November 2025
Read MoreTECH TRANSFER EXCELLENCE: WHY SMOOTH TECHNOLOGY TRANSFERS MATTER IN API MANUFACTURING
Tech Transfer Excellence: Why Smooth Technology Transfers Matter in API Manufacturing
12 November 2025
Read MoreROUTE SCOUTING IN API DEVELOPMENT: HOW TO CHOOSE THE RIGHT SYNTHETIC PATHWAY
Route Scouting in API Development: How to Choose the Right Synthetic Pathway
10 November 2025
Read MoreTHE LIFECYCLE OF AN API: FROM R&D TO COMMERCIAL SCALE MANUFACTURING
The lifecycle of an API is a journey of transformation from lab curiosity to life-saving compound. Every gram produced carries the weight of patient lives, regulatory scrutiny, and commercial expectations.
14 November 2025
Read MoreGREEN CHEMISTRY IN API MANUFACTURING: HOW CDMOs ARE DRIVING SUSTAINABILITY
In an industry where precision and purity are non-negotiable, the pharmaceutical sector is now confronting a new imperative: Sustainability. As climate change accelerates and environmental regulations tighten, green chemistry has emerged as a powerful tool in reimagining how Active Pharmaceutical Ingredients (APIs) are developed and manufactured.
09 November 2026
Read MoreClose
